(Q34646419)

3 August 2017

title

Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study (English)

1 reference

3 August 2017

1 reference

Gregory L Willis

1

1 reference

3 August 2017

E John D Turner

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Chronobiology International

3 August 2017

published in

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

521-537

1 reference

Parkinson's disease and sleepiness: an integral part of PD.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Study of circadian melatonin secretion pattern at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Dose-response relationship between light irradiance and the suppression of plasma melatonin in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Effect of L-dopa on the seborrhoea of Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Melatonin modulates apomorphine-induced rotational behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Melatonin levels in Parkinson's disease: drug therapy versus electrical stimulation of the internal globus pallidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Metabolic modification of Parkinson's disease and of chronic manganese poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Physiological and radiological implications of a low incidence of pineal calcification in Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Sleep deprivation therapy in depressive illness and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

ECT and Parkinson's disease revisited: a "naturalistic" study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

The assessment of light intensity preference in psychiatric patients: a questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Pineal gland in old age; quantitative and qualitative morphological study of 168 human autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Intracranial calcification in paediatric computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

On pineal calcification and its relation to subjective sleep perception: a hypothesis-driven pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Light suppresses melatonin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Adjunctive bright light in non-seasonal major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Relations between on-off phenomena and cognitive functions in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Depression associated with Parkinson's disease: clinical features and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Sex and strain related effects of melatonin and 5-methoxytryptophol on open field behaviour in paired mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

The effect of sleep deprivation on motor impairment and retinal adaptation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Atenolol in seasonal affective disorder: a test of the melatonin hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Morphologic changes in the pineal parenchyma cells of rats exposed to continuous light or darkness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Ethics, standards, and procedures of animal and human chronobiology research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Effect of light wavelength on suppression and phase delay of the melatonin rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Light emitting diodes can be used to phase delay the melatonin rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

AGE AND ENZYME ACTIVITY IN THE HUMAN PINEAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07420520701420717

10.1080/07420520701420717

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference